Encompass Health Corp

Encompass Health Corp owns and operates inpatient rehabilitation hospitals that treat patients recovering from major injury or illness and needing intensive therapy to regain function and independence. It is the largest U.S. operator in this niche by patients treated, revenue, and hospital count, with a network spanning 39 states and Puerto Rico.

9,5 %

+10,5 %

1.08

1.08

— Encompass Health Corp
%
Inpatient rehabilitation hospital services90% Specialized inpatient care and therapy for patients recovering from major injury or illness.
Non-patient care revenue10% State directed and supplemental payments plus management and administrative fees.

The company serves patients referred after acute-care hospitalization who need intensive rehabilitation before...

  • Patient referrals from acute-care hospitalsprimary

    Hospitals discharge patients needing intensive rehab; this is the main source of admissions and is strategically critical.

  • Medicare and Medicare Advantage beneficiariesprimary

    Older and medically complex patients whose reimbursement drives a large share of operating revenue.

  • Commercial and managed care payorssecondary

    Insured patients whose contracts and utilization rules affect pricing and admission flow.

  • Medicaid patients and state programssecondary

    Patients covered by Medicaid, including supplemental payment programs that support revenue.

  • Physicians, case managers, and referral networksprimary

    Influence patient placement decisions and determine access to admissions in local markets.

Encompass Health operates across 39 states and Puerto Rico, with especially heavy concentration in Florida and Texas...

  • Operations span 39 states and Puerto Rico
  • Florida and Texas are the largest concentration markets
  • Local referral density drives admissions and utilization
  • Certificate-of-need states can limit new competition
  • De novo growth targets Sun Belt and other high-demand markets

The company is expanding capacity through de novo hospitals, joint ventures, remote and satellite hospitals, and bed...

01
De novo hospital expansion and bed additionsmedium-term

Adds capacity in markets with strong demand and supports long-term volume growth.

02
Referral-source relationship managementshort-term

Admissions depend heavily on acute-care hospital and physician referrals.

03
Operational quality and cost efficiencymedium-term

Better outcomes and lower cost per episode strengthen payer and referral acceptance.

04
Balance sheet flexibilityshort-term

Supports growth and cushions reimbursement or regulatory volatility.

The biggest risk is reimbursement pressure, especially from Medicare, Medicaid, and managed care, because the company’s...

high

Reimbursement reductions or rule changes

A large share of revenue comes from Medicare and other regulated payors.

Scope
Medicare, Medicaid, managed care
Materiality
high
high

Referral-source concentration

About 92% of admissions come from acute-care hospitals, so referral shifts can quickly affect volumes.

Scope
Acute-care hospital networks and physician relationships
Materiality
high
high

Regulatory and Medicare compliance

Failure to meet conditions of participation or anti-kickback rules could disrupt operations.

Scope
Hospital-level compliance and billing practices
Materiality
high
medium

Competitive pressure in local markets

Other post-acute providers and acute-care systems can expand rehab offerings and compete for patients.

Scope
Local market share and admissions
Materiality
medium
medium

Acquisition and joint venture execution

Growth strategy relies on transactions that can face approvals, integration issues, and hidden liabilities.

Scope
De novo projects, JVs, acquisitions
Materiality
medium
Revenue recognition estimates
Affects reported revenue, receivables, and margin timing
Medicare and Medicaid reimbursement settlements
Can change revenue and other income across periods
Supplemental payments and provider taxes
Affects operating revenue mix and expense comparability
Asset depreciation and impairment
Influences operating profit and non-cash charges

: 28/04/2026